TLIS - Talis Biomedical regains compliance with Nasdaq's minimum bid price rule

2023-07-24 08:13:19 ET

• Diagnostic company Talis Biomedical ( NASDAQ: TLIS ) said on Monday that it has regained compliance with Nasdaq's minimum bid price requirement of at least $1.00 per share.
• The news comes after Talis Biomedical announced a 1-for-15 reverse stock split to increase the value of its shares.
• The company's shares were required to maintain a closing bid price of at least $1.00 per share for a minimum of ten consecutive business days, which was satisfied on July 19.
• The stock exchange now considers the matter as closed.
• Source: Press Release

For further details see: